In this episode, the P4A team discussed the impact of cost-containment measures in Germany, the European Commission's recent move to revise legislation on orphan medicinal products and potential legislative reforms in the US under the new Biden administration.
Presenter: Jens Leutloff
Contributors: Chloe Sheppard, Max Rex
Producer: Aparna Krishnan
Create your
podcast in
minutes
It is Free